Skip to main content

Advertisement

Log in

Improvement of Cardiovascular Function in Aging Females by the Prolonged Activation of G Protein-Coupled Estrogen Receptor

  • Original Article
  • Published:
Journal of Cardiovascular Translational Research Aims and scope Submit manuscript

Abstract

Ample evidence suggests that estrogen replacement therapy is associated with beneficial effects with regard to cardiovascular diseases when the therapy is initiated temporally close to menopause but not when it is initiated later. Little is known about the complex interactions between hormone receptors after menopause. Coronary artery function and cardiac function were measured in rats that had either received no treatment or had been pretreated with an androgen receptor (AR) antagonist and/or a GPER agonist G-1. ICI 182,780 was used to block the classical estrogen receptors (ERs) to investigate their complex interactions with GPER. The beneficial effects of GPER were only observed by blocking ARs and classical ERs in aged female rats. The results demonstrate that GPER activation is a potential therapeutic target for the inhibition of age-dependent coronary artery dysfunction and cardiac dysfunction under the condition of blocking ARs and classical ERs after menopause.

Clinical Relevance

The risk of cardiovascular disease in postmenopausal women significantly increased. The role of sex hormones and their receptors during this process is still complicated. Our present study demonstrated that the imbalance of androgen and estrogen may contribute to the impairment of vascular reactivity and subsequent cardiac function. Treatment with GPER agonist G1 combined with the inhibition of ERα and ERβ could improve vascular function and reduce the myocardial ischemia reperfusion injury. These findings may provide the novel and effective strategy for the treatment of cardiovascular diseases in postmenopausal women.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

ACh:

Acetylcholine

AR:

Androgen receptor

CK:

Creatine kinase

DHE:

Dihydroethidium

ER:

Estrogen receptors

GPER:

G protein-coupled estrogen receptor

HRT:

Estrogen replacement therapy

LVDP:

Left ventricular diastolic pressure

LVEDP:

Left ventricular end-diastolic pressure

LVSP:

Left ventricular systolic pressure

PE:

Phenylephrine

ROS:

Reactive oxygen species

TUNEL:

Terminal deoxynucleotidyl transferase dUTP nick end labeling

References

  1. Sotelo MM, Johnson SR. The effects of hormone replacement therapy on coronary heart disease. Endocrinol Metab Clin North Am. 1997;26(2):313–28.

    Article  CAS  PubMed  Google Scholar 

  2. Waters DD, Alderman EL, Hsia J, Howard BV, Cobb FR, Rogers WJ, Ouyang P, Thompson P, Tardif JC, Higginson L, Bittner V, Steffes M, Gordon DJ, Proschan M, Younes N, Verter JI. Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. JAMA. 2002;288(19):2432–40.

    Article  CAS  PubMed  Google Scholar 

  3. Anagnostis P, Lambrinoudaki I, Stevenson JC, Goulis DG. Menopause-associated risk of cardiovascular diseaseEndocr Connect. 2022;11(4):e210537.

  4. Debortoli AR, Rouver WDN, Delgado NTB, Mengal V, Claudio ERG, Pernomian L, Bendhack LM, Moyses MR, Santos RLD. GPER modulates tone and coronary vascular reactivity in male and female rats. J Mol Endocrinol. 2017;59(2):171–80.

    Article  CAS  PubMed  Google Scholar 

  5. Hodis HN, Mack WJ, Henderson VW, Shoupe D, Budoff MJ, Hwang-Levine J, Li Y, Feng M, Dustin L, Kono N, Stanczyk FZ, Selzer RH, Azen SP, ER Group. Vascular effects of early versus late postmenopausal treatment with estradiol. N Engl J Med. 2016;374(13):1221-31.

  6. Sunday L, Osuna C, Krause DN, Duckles SP. Age alters cerebrovascular inflammation and effects of estrogen. Am J Physiol Heart Circ Physiol. 2007;292(5):H2333–40.

    Article  CAS  PubMed  Google Scholar 

  7. Ajayi AA, Ogungbade GO, Okorodudu AO. Sex hormone regulation of systemic endothelial and renal microvascular reactivity in type-2 diabetes: studies in gonadectomized and sham-operated Zucker diabetic rats. Eur J Clin Invest. 2004;34(5):349–57.

    Article  CAS  PubMed  Google Scholar 

  8. Mukherjee TK, Reynolds PR, Hoidal JR. Differential effect of estrogen receptor alpha and beta agonists on the receptor for advanced glycation end product expression in human microvascular endothelial cells. Biochim Biophys Acta. 2005;1745(3):300–9.

    Article  CAS  PubMed  Google Scholar 

  9. Sherwood A, Bower JK, McFetridge-Durdle J, Blumenthal JA, Newby LK, Hinderliter AL. Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women. Arterioscler Thromb Vasc Biol. 2007;27(8):1782–7.

    Article  CAS  PubMed  Google Scholar 

  10. Miller AP, Xing D, Feng W, Fintel M, Chen YF, Oparil S. Aged rats lose vasoprotective and anti-inflammatory actions of estrogen in injured arteries. Menopause. 2007;14(2):251–60.

    Article  PubMed  Google Scholar 

  11. Bowling MR, Xing D, Kapadia A, Chen YF, Szalai AJ, Oparil S, Hage FG. Estrogen effects on vascular inflammation are age dependent: role of estrogen receptors. Arterioscler Thromb Vasc Biol. 2014;34(7):1477–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Lindsey SH, da Silva AS, Silva MS, Chappell MC. Reduced vasorelaxation to estradiol and G-1 in aged female and adult male rats is associated with GPR30 downregulation. Am J Physiol Endocrinol Metab. 2013;305(1):E113–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Tang HC, Cheng YY, Guo HR. Association between hormone replacement therapy and carpal tunnel syndrome: a nationwide population-based study. BMJ Open. 2022;12(1):e055139.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Lambrinoudaki I, Christodoulakos G, Rizos D, Economou E, Argeitis J, Vlachou S, Creatsa M, Kouskouni E, Botsis D. Endogenous sex hormones and risk factors for atherosclerosis in healthy Greek postmenopausal women. Eur J Endocrinol. 2006;154(6):907–16.

    Article  CAS  PubMed  Google Scholar 

  15. Reckelhoff JF, Roman RJ. Androgens and hypertension: role in both males and females?. Hypertension. 2011;57(4):681–2.

    Article  CAS  PubMed  Google Scholar 

  16. Miao Q, Wang S, Miao S, Wang J, Xie Y, Yang Q. Cardioprotective effect of polydatin against ischemia/reperfusion injury: roles of protein kinase C and mito K(ATP) activation. Phytomedicine. 2011;19(1):8–12.

    Article  CAS  PubMed  Google Scholar 

  17. Collard CD, Gelman S. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology. 2001;94(6):1133–8.

    Article  CAS  PubMed  Google Scholar 

  18. Querio G, Antoniotti S, Geddo F, Tullio F, Penna C, Pagliaro P, Gallo MP. Ischemic heart disease and cardioprotection: focus on estrogenic hormonal setting and microvascular health. Vascul Pharmacol. 2021;141:106921.

    Article  CAS  PubMed  Google Scholar 

  19. Rocca C, Femmino S, Aquila G, Granieri MC, De Francesco EM, Pasqua T, Rigiracciolo DC, Fortini F, Cerra MC, Maggiolini M, Pagliaro P, Rizzo P, Angelone T, Penna C. Notch1 mediates preconditioning protection induced by GPER in normotensive and hypertensive female rat hearts. Front Physiol. 2018;9:521.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Li Z, Cheng L, Liang H, Duan W, Hu J, Zhi W, Yang J, Liu Z, Zhao M, Liu J. GPER inhibits diabetes-mediated RhoA activation to prevent vascular endothelial dysfunction. Eur J Cell Biol. 2016;95(2):100–13.

    Article  CAS  PubMed  Google Scholar 

  21. Li ZL, Liu JC, Liu SB, Li XQ, Yi DH, Zhao MG. Improvement of vascular function by acute and chronic treatment with the GPR30 agonist G1 in experimental diabetes mellitus. PLoS ONE. 2012;7(6):e38787.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Weil BR, Manukyan MC, Herrmann JL, Wang Y, Abarbanell AM, Poynter JA, Meldrum DR. Signaling via GPR30 protects the myocardium from ischemia/reperfusion injury. Surgery. 2010;148(2):436–43.

    Article  PubMed  Google Scholar 

  23. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, I. Writing Group for the Women’s Health Initiative. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288(3):321–33.

  24. Taylor JE, Baig MS, Helmy T, Gersh FL. Controversies regarding postmenopausal hormone replacement therapy for primary cardiovascular disease prevention in women. Cardiol Rev. 2021;29(6):296–304.

    PubMed  Google Scholar 

  25. Georgiopoulos GA, Lambrinoudaki I, Athanasouli F, Armeni E, Rizos D, Kazani M, Karamanou M, Manios E, Augoulea A, Stellos K, Papamichael C, Stamatelopoulos K. Free androgen index as a predictor of blood pressure progression and accelerated vascular aging in menopause. Atherosclerosis. 2016;247:177–83.

    Article  CAS  PubMed  Google Scholar 

  26. Xie W, Ren M, Li L, Zhu Y, Chu Z, Zhu Z, Ruan Q, Lou W, Zhang H, Han Z, Huang X, Xiang W, Wang T, Yao P. Perinatal testosterone exposure potentiates vascular dysfunction by ERbeta suppression in endothelial progenitor cells. PLoS One. 2017;12(8):e0182945.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Soisson V, Brailly-Tabard S, Helmer C, Rouaud O, Ancelin ML, Zerhouni C, Guiochon-Mantel A, Scarabin PY. A J-shaped association between plasma testosterone and risk of ischemic arterial event in elderly men: the French 3C cohort study. Maturitas. 2013;75(3):282–8.

    Article  CAS  PubMed  Google Scholar 

  28. Hutchison SJ, Sudhir K, Chou TM, Sievers RE, Zhu BQ, Sun YP, Deedwania PC, Glantz SA, Parmley WW, Chatterjee K. Testosterone worsens endothelial dysfunction associated with hypercholesterolemia and environmental tobacco smoke exposure in male rabbit aorta. J Am Coll Cardiol. 1997;29(4):800–7.

    Article  CAS  PubMed  Google Scholar 

  29. Fogle RH, Stanczyk FZ, Zhang X, Paulson RJ. Ovarian androgen production in postmenopausal women. J Clin Endocrinol Metab. 2007;92(8):3040–3.

    Article  CAS  PubMed  Google Scholar 

  30. Gershagen S, Doeberl A, Jeppsson S, Rannevik G. Decreasing serum levels of sex hormone-binding globulin around the menopause and temporary relation to changing levels of ovarian steroids, as demonstrated in a longitudinal study. Fertil Steril. 1989;51(4):616–21.

    Article  CAS  PubMed  Google Scholar 

  31. Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet. 1999;353(9147):89–92.

    Article  CAS  PubMed  Google Scholar 

  32. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation. 1999;99(9):1165–72.

    Article  CAS  PubMed  Google Scholar 

  33. Regitz-Zagrosek V. Therapeutic implications of the gender-specific aspects of cardiovascular disease. Nat Rev Drug Discov. 2006;5(5):425–38.

    Article  CAS  PubMed  Google Scholar 

  34. Querio G, Geddo F, Antoniotti S, Gallo MP, Penna C. Sex and response to cardioprotective conditioning maneuvers. Front Physiol. 2021;12:667961.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Xiang D, Liu Y, Zhou S, Zhou E, Wang Y. Protective effects of estrogen on cardiovascular disease mediated by oxidative stress. Oxid Med Cell Longev. 2021;2021:5523516.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Barsha G, Colafella KM Mirabito, Walton SL, Gaspari TA, Spizzo I, Pinar AA, Krause LM Hilliard, Widdop RE, Samuel CS, Denton KM. In aged females, the enhanced pressor response to angiotensin II Is attenuated by estrogen replacement via an angiotensin type 2 receptor-mediated mechanism. Hypertension. 2021;78(1):128–137.

  37. Yue YX, Zhai JY, Du HB, Jiang LN, Zhang LM, Wang C, Zhao ZA, Zhang CH, Zhao ZG. Estrogen enhances the microvascular reactivity through RhoA-ROCK pathway in female mice during hemorrhagic shock. Shock. 2021;56(4):611–20.

    Article  CAS  PubMed  Google Scholar 

  38. Pinkerton JV. Hormone therapy for postmenopausal women. N Engl J Med. 2020;382(5):446–55.

    Article  PubMed  Google Scholar 

  39. Chakrabarti S, Davidge ST. G-protein coupled receptor 30 (GPR30): a novel regulator of endothelial inflammation. PLoS One. 2012;7(12):e52357.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work was supported by the National Natural Science Foundation of China (82070264 82070503, 81400276), the China Postdoctoral Science Foundation (Grant No: 2013M542442), and the Key R&D Program of Shaanxi Province (2022ZDLSF01-09).

Author information

Authors and Affiliations

Authors

Contributions

JL and ZL conceived and designed the experiments; JM, JH, and XW performed the experiments; JH and SZ established the animal models; XW and ZL analyzed the data; JM, ZL, and JL wrote, revised, and checked the manuscript. All authors have reviewed the contents of the manuscript, validated the accuracy of the data, and approved the submitted manuscript.

Corresponding authors

Correspondence to Zilin Li or Jincheng Liu.

Ethics declarations

Ethics Approval

The present study was performed in accordance with the National Institutes of Health guidelines for the use of experimental animals, and all animal protocols were approved by the Committee for Ethical Use of Experimental Animals of the Fourth Military Medical University (No: 20150107).

Conflict of Interest

The authors declare no competing interests.

Additional information

Associate Editor Nicola Smart oversaw the review of this article

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 873 KB)

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ma, J., Hu, J., Wang, X. et al. Improvement of Cardiovascular Function in Aging Females by the Prolonged Activation of G Protein-Coupled Estrogen Receptor. J. of Cardiovasc. Trans. Res. 16, 371–381 (2023). https://doi.org/10.1007/s12265-022-10315-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12265-022-10315-z

Keywords

Navigation